Jim Simons Exicure, Inc. Call Options Transaction History
Renaissance Technologies LLC
- $63.6 Billion
- Q1 2024
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding XCUR
# of Institutions
21Shares Held
860KCall Options Held
0Put Options Held
0-
Abingworth LLP London, X0282KShares$90,1230.11% of portfolio
-
Carlyle Group Inc. Washington, DC282KShares$90,1230.01% of portfolio
-
Geode Capital Management, LLC Boston, MA56.5KShares$18,0860.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA40.1KShares$12,8290.0% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny34.8KShares$11,1360.0% of portfolio
About EXICURE, INC.
- Ticker XCUR
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 4,962,580
- Market Cap $1.59M
- Description
- Exicure, Inc., a biotechnology company, develops therapies for neurological disorders and hair loss based on its proprietary spherical nucleic acid (SNA) technology. Its lead program candidate includes SCN9A that is in preclinical studies for neuropathic and chronic pain. The company has a collaboration, option, and license agreement with AbbVie...